Differences in absolute risk of cardiovascular events using risk-refinement tests: a systematic analysis of four

Emil M deGoma1, Richard L Dunbar, Douglas Jacoby

  • 1Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, PA, USA. emil.deGoma@uphs.upenn.edu

Atherosclerosis
|January 26, 2013
PubMed

Insights

Cardiovascular risk assessment using C-reactive protein (CRP), carotid intima-media thickness (CIMT), and coronary artery calcium (CAC) thresholds can significantly alter absolute risk calculations. Coronary artery calcium (CAC) showed the greatest impact on absolute risk predictions.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Medical Diagnostics

Background:

  • Current cardiovascular risk assessment guidelines utilize C-reactive protein (CRP), carotid intima-media thickness (CIMT), and coronary artery calcium (CAC) in select populations.
  • Thresholds for higher and lower cardiovascular risk are defined for these tests, but their impact on absolute global risk is not fully understood.

Purpose of the Study:

  • To evaluate the effect of established risk thresholds for CRP, CIMT, and CAC on absolute cardiovascular risk estimates.
  • To compare the impact of these risk refinement tests when incorporated into different validated risk prediction equations.

Main Methods:

  • Systematic permutation of risk factors to generate 10-year risk estimates using Framingham, MESA, ARIC, and Reynolds risk scores.
  • Defined low, high, and very-high risk values for CAC (Agatston units), CIMT (percentiles), and hsCRP (mg/L).

Main Results:

  • Incorporating coronary artery calcium (CAC) values into the MESA risk score led to more substantial changes in absolute risk compared to the Framingham risk score.
  • The impact of CAC on absolute risk was greater than that of CIMT or hsCRP when using ARIC or Reynolds risk scores.

Conclusions:

  • Designated low, high, and very-high risk values for CAC, CIMT, and hsCRP result in significantly different absolute cardiovascular risk levels when applied within validated risk equations.
  • Calculating absolute cardiovascular risk using validated risk equations is recommended over relying solely on risk-marker thresholds derived from relative risk estimates.
Abstract

Related Concept Videos

Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Renal Drug Clearance: Comparison Between Renal Excretion Methods01:08

Renal Drug Clearance: Comparison Between Renal Excretion Methods

Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...